Cel Sci Corporation (CVM)

[drkazmd65]

Greetings ducruacuteo11 - welcome to the board.

I have wondered that myself at times as at least some of the early patients should have completed the course of treatment and have been monitored for enough of a length of time.

The only 'good' answer to that I have been able to come up with in my mind is essentially this:

As pointed out in the last PR on the topic (from Monday, 1/5/15) - There has been a really significant uptick in patient enrollment (even though it still is painfully slow) since December 2014. 328 patients total since the Phase III testing started. However - over 200 of these since 2014 who are nowhere near close to the point where a primary result measure could be taken.

http://ih.advfn.com/p.php?pid=nmona&article=64980897

So maybe there are 50-70, patients who have completed the testing (could be fewer), and who have reached the endpoint for primary measure tabulation. Remember - about half of these patients are a control group so maybe ~30 who received treatment with Multikine are there to base the data upon. The study may have started officially in December 2010 - but very few patients are done. Might not be enough data to see a statistical difference yet - or there might just not be a big difference to be seen.

I don't know of any specific examples of companies who have released results of Phase III testing while still conducting Phase III testing though. Or for that matter am not aware of any companies that have released results from Phase I or Phase II testing during those phases of testing either.

I'm still on the fence as to whether Multikine actually will work - and that's why I've not been adding shares - although I haven't sold any shares yet either.

I'm mostly waiting to see at this point whether the lawsuit against the old CRO brings a positive cash input - and whether the Multikine Vs. HPV warts Phase I shows any promising results.

That should start to resolve itself sometime this Spring or Summer.